ClinicalTrialsFinder

Macular Dystrophy Clinical Trials in Cincinnati, Ohio

1 recruitingCincinnati, Ohio

Showing 1–1 of 1 trials

Recruiting
Phase 1Phase 2

Safety and Tolerability of Subretinally Injected OPGx-BEST1 in Patients With Best Vitelliform Macular Dystrophy (BVMD) or Autosomal-Recessive Bestrophinopathy (ARB)

ARBBVMDAutosomal-Dominant Bestrophinopathy+1 more
Opus Genetics, Inc10 enrolled4 locationsNCT07185256